RU2012149873A - METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN - Google Patents
METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN Download PDFInfo
- Publication number
- RU2012149873A RU2012149873A RU2012149873/15A RU2012149873A RU2012149873A RU 2012149873 A RU2012149873 A RU 2012149873A RU 2012149873/15 A RU2012149873/15 A RU 2012149873/15A RU 2012149873 A RU2012149873 A RU 2012149873A RU 2012149873 A RU2012149873 A RU 2012149873A
- Authority
- RU
- Russia
- Prior art keywords
- gestation
- trimester
- human immunoglobulin
- evaluating
- reduction
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Способ оценки снижения содержания серотонина в периферической крови беременных в третьем триместре гестации путем лечения человеческим иммуноглобулином, характеризующегося тем, что при обострении герпес-вирусной инфекции во втором триместре гестации вводится на 16 и 24 неделях беременности внутривенно человеческий иммуноглобулин по 25 мл внутривенно капельно трижды через день, что приводит к снижению в третьем триместре к 36 неделе гестации содержания серотонина до 0,56±0,02 мкмоль/л по сравнению с исходным количеством 1,72±0,09 мкмоль/л во втором триместре гестации при обострении герпес-вирусной инфекции, что предотвращает повреждение органов фетоплацентарной системы.A method of evaluating the reduction of serotonin in the peripheral blood of pregnant women in the third trimester of gestation by treatment with human immunoglobulin, characterized in that, with an exacerbation of herpes virus infection in the second trimester of gestation, a human immunoglobulin of 25 ml is administered intravenously drip three times every other day at 16 and 24 weeks of gestation , which leads to a decrease in the third trimester by week 36 of gestation of the serotonin content to 0.56 ± 0.02 μmol / L compared with the initial amount of 1.72 ± 0.09 μmol / L in the second rum trimester of gestation with exacerbation of herpes virus infection, which prevents damage to the organs of the fetoplacental system.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012149873/15A RU2530617C2 (en) | 2012-11-22 | 2012-11-22 | Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012149873/15A RU2530617C2 (en) | 2012-11-22 | 2012-11-22 | Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012149873A true RU2012149873A (en) | 2014-05-27 |
RU2530617C2 RU2530617C2 (en) | 2014-10-10 |
Family
ID=50775188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012149873/15A RU2530617C2 (en) | 2012-11-22 | 2012-11-22 | Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2530617C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1173191A4 (en) * | 1997-05-13 | 2004-12-01 | Univ California | Novel antiangiogenic peptide agents and their therapeutic and diagnostic use |
RU2306564C1 (en) * | 2006-05-10 | 2007-09-20 | ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" | Method for predicting chronic fetoplacental insufficiency |
-
2012
- 2012-11-22 RU RU2012149873/15A patent/RU2530617C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2530617C2 (en) | 2014-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ716473A (en) | Diagnosis and therapy of cancer involving cancer stem cells | |
EA201491330A1 (en) | THERAPEUTICALLY ACTIVE CONNECTIONS AND METHODS OF THEIR USE | |
EA201690212A1 (en) | METHODS OF TREATMENT OR PREVENTION OF OPHTHALMIC PATHOLOGICAL CONDITIONS | |
WO2015054619A8 (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia | |
WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
EA201590332A1 (en) | PHARMACEUTICAL COMBINATIONS CONTAINING B-RAF INHIBITOR, EGFR INHIBITOR AND, OPTIONAL, PI3K-ALPHA INHIBITOR | |
MX2015007147A (en) | A method of reducing brain amyloid plaques using anti-aã antibodies. | |
RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
EA201400002A1 (en) | METHODS TO TREAT DISEASES OF THE RETAIL | |
JP2016501219A5 (en) | ||
EA201791960A1 (en) | APPLICATION OF LEMON-ACID IRON IN THE TREATMENT OF THE CAUSED DEFICIENCY OF THE IRON ANEMIA | |
RU2014103543A (en) | Botulinum toxins for use in the treatment of fatty deposits | |
RU2012149873A (en) | METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN | |
FI3137094T3 (en) | Treatment and prevention of alzheimer's disease (ad) | |
RU2013155841A (en) | METHOD FOR EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE | |
EA202091446A1 (en) | METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
RU2010133699A (en) | METHOD FOR COMBINED TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY | |
RU2011108787A (en) | METHOD FOR TREATING PATIENTS WITH RED PLANE | |
RU2012101073A (en) | METHOD FOR TREATING PATIENTS WITH POLYORGANIC OZONE THERAPY PATHOLOGY | |
EA202091087A1 (en) | METHODS FOR REDUCING THE SIDE EFFECTS OF THERAPY WITH ANTIBODY AGAINST CD30-DRUG CONJUGATE | |
EA201200443A1 (en) | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION | |
RU2010147437A (en) | METHOD FOR TREATING SHOCK CONDITION IN NEWBORNS WITH SURGICAL PATHOLOGY | |
RU2010145617A (en) | METHOD FOR TREATING PATIENTS WITH CRANIO-BRAIN INJURY ON THE BACKGROUND OF HYPERTENSION SYNDROME IN THE ACUTE PERIOD | |
RU2012135942A (en) | METHOD FOR TREATING PATIENTS WITH GALLSTONE DISEASE OF THE FIRST STAGE | |
UA80461U (en) | Method for treating placental dysfunction in pregnant patients with pre-eclampsia with concomitant hepatobiliary pathology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20140519 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20141123 |